James from Spain

Registered at the short selling broker Skilling, 2 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Amyris, Inc. (AMRS) shares information

Amyris, Inc.


24h Change

7.02 %

AMRS

Live rate: Market closed

Stock data per Friday 23 Oct, 2020

AMRS
NASDAQ
2.85
2.9
3.05
0.2 (+ 7.02%)
US Market is closed

Live Stock price in graph for Amyris, Inc. (AMRS)

  • Latest Volume

    2,231,852 (39.84 %)

  • Volume prev. day

    1,596,024

  • Avg. daily volume

    2,218,219

  • Market cap

    624,429,550

  • P/E ratio

    -1.31

  • Today high

    3.06

  • Today low

    2.855

  • 52 week high

    6.07

  • 52 week low

    1.4

  • YTD Change

    + 6.37 %

Quick links

Price target by analysts

The 2 latest analyst estimates, per Tuesday 18 August, 2020, show the following high, low and average price targets.
Target Average: 10 USD
Target High: 11 USD
Target Low: 9 USD

 

Latest news about Amyris, Inc.

Below you can find the most recent news posts about Amyris, Inc., primarily from US and UK based news sources.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

Saturday, 24 October 2020, 01:06:00
LOS ANGELES–(BUSINESS WIRE)—- $AMRS #CLASSACTION–Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors
— Business Wire


Amyris and Arzeda Enter into Development Collaboration Agreement

Tuesday, 20 October 2020, 15:30:00
SEATTLE, Oct. 20, 2020 /PRNewswire/ — Arzeda, the Protein Design Company™, today announced that the company has entered into a joint development agreement with Amyris that leverages the complementary nature of the two companies’ technology platforms to accelerate the development and…
— PR Newswire


The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

Thursday, 8 October 2020, 15:00:00
LOS ANGELES–(BUSINESS WIRE)—- $AMRS #classaction–The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Amyris, Inc (“Amyris” or the “Company”) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On March 19, 2019, Amyris announced was unable to file its annual report for fiscal year ended December 31, 2018 on time due to “the significant time and resources that were devoted to
— Business Wire


Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant – Enabling Vaccines For All With No Sharks Killed

Thursday, 1 October 2020, 14:30:00
EMERYVILLE, Calif., Oct. 1, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it is currently…
— PR Newswire


Amyris’ Pipette Clean Baby Brand Selected By Alibaba For Accelerated Entry Into China For Singles’ Day Sales

Monday, 21 September 2020, 14:30:00
EMERYVILLE, Calif., Sept. 21, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that its Pipette® baby and…
— PR Newswire


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have AMRS available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.